file8k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
________________
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of Earliest Event Reported) – February 18, 2010
________________________
WEST
PHARMACEUTICAL SERVICES, INC.
(Exact
name of registrant as specified in its charter)
_____________________
|
|
|
Pennsylvania
|
1-8036
|
23-1210010
|
(State
or other jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
|
|
|
101
Gordon Drive, PO Box 645, Lionville, PA
|
|
19341-0645
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(610)
594-2900
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or address, if changed since last report)
____________________
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02 Results
of Operations and Financial Condition
On
February 18, 2010, West Pharmaceutical Services, Inc. (the “Company”) issued a
press release announcing the Company’s financial results for the three and
twelve-month periods ended December 31, 2009. A copy of the press release
is attached hereto as Exhibit 99.1 and incorporated herein by
reference.
Item
9.01 Financial
Statements, Pro Forma Financial Information and Exhibits.
Exhibit
# Description
99.1 West Pharmaceutical Services, Inc.
Press Release, dated February 18, 2010.
EXHIBIT
INDEX
Description
99.1 West
Pharmaceutical Services, Inc. Press Release, dated February 18,
2010.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
WEST
PHARMACEUTICAL SERVICES, INC.
/s/ William J.
Federici
William
J. Federici
Vice
President and Chief Financial Officer
February
18, 2010